Working… Menu

Clinical Bioequivalence Study on Two Methyldopa Tablet 250mg Formulations

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT03210025
Recruitment Status : Completed
First Posted : July 6, 2017
Last Update Posted : January 18, 2018
Chinese University of Hong Kong
Information provided by (Responsible Party):
Bright Future Pharmaceuticals Factory O/B Bright Future Pharmaceutical Laboratories Limited

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : October 15, 2017
Actual Study Completion Date : October 15, 2017